Hyperkalemia has been linked to several factors including reduced eGFR, treatment with renin–angiotensin–aldosterone system (RAAS) blockers and a cellular shift due to the presence of acidosis or diabetes (Moranne et al., 2009; Seliger et al., 2008; Williams, 1991). The gene discussed is REN; the disease is Hyperkalemia.